Finance · Search · Sign in · Sign up

Filomena buys IMGN 12.02: Synta Pharmaceuticals : Biotech Equities Ahead of Market -- Research on Vertex Pharma, NewLink Genetics, ImmunoGen, and Synta Ph ...


NLNK), ImmunoGen Inc. (NASDAQ: IMGN) and Synta Pharmaceuticals Corp. (NASDAQ: SNTA). Free technical research on VRTX, NLNK, IMGN and SNTA can be downloaded upon signing up at: http://ift.tt/1hAtrEB On Wednesday, Vertex Pharmaceuticals ... ...


35 people liked this



See more

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

<< Home